Tension Free Vaginal Tape (TVT) Versus the Miniarc Sling
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00843908|
Recruitment Status : Completed
First Posted : February 13, 2009
Last Update Posted : August 27, 2009
The aim of this study is to assess whether the Miniarc suburethral sling is equivalent to the TVT in the treatment of women with urodynamic stress incontinence (USI). If equivalence is proven, the advantages to women with USI will be potentially significant since the Miniarc may be carried out as an office based procedure, negating the need for an anaesthetic and hospital admission. The investigators null hypothesis is that there is no difference in subjective or objective outcome between the TVT and the Miniarc in the treatment of USI.
Eligible women will be initially assessed with a full history and examination, King's Health Questionnaire and twin channel subtraction cystometry. They will be randomised (using a series of numbered opaque envelopes) to undergo either the TVT or Miniarc. Follow up will be at 6 weeks, with a subjective outcome measure and at 6 months with a repeat subjective assessment and repeat twin channel cystometry.
|Condition or disease||Intervention/treatment||Phase|
|Urodynamic Stress Incontinence||Device: Tension Free Vaginal Tape Device: Miniarc||Not Applicable|
Description Randomised, prospective study. Objective and subjective outcomes to be evaluated 6 weeks an d6 months post-operatively.
Study population The number of patients enrolled in the study will be decided after consultation with a statistician.
All patients will be recruited from urogynaecology clinics at Medway Maritime Hospital. They will be female and have a urodynamic diagnosis of stress incontinence, having failed conservative management. Those deemed suitable for the TVT operation will be offered entry to the study.
Randomisation and blinding
Patients who have consented to take part in the study will be randomised to have either a conventional TVT (Group A) or a MiniArc (Group B). Each group will be run in parallel. Method of randomisation - consecutively numbered opaque envelopes detailing type of operation.
Patients will be blinded as to the type of tape used. Due to the obvious differences between the devices, it will not be possible to blind researchers to the type of tape.
Each patient will undergo a pre-operative assessment (which may be incorporated into the initial clinic visit), be admitted as an in-patient for the TVT/Mini-arc procedure, and attend a post-operative assessment visit. This last visit will be the exit point from the study. These are detailed below
- Detailed symptom history and examination
- 3 day urinary diary
- King's Quality of Life questionnaire
- Dual channel normal saline subtracted cystometry at a filling rate of 50-100ml/min whilst supine and standing. 7F double lumen catheter used for all measurements
Group A will have the TVT inserted under spinal anaesthesia as described by Ulmsten12. Group B will have the MiniArc tape inserted under spinal anaesthesia. All procedures will be undertaken in an operating theatre environment, and carried out by Mr Duckett or a member of his team who has undergone appropriate training. Patients will be catheterised until 6 hours post-operatively. Those who void with a residual of less than 100mls will be discharged the day after the procedure.
- Carried out at 6 weeks' post-operatively
- Symptoms assessed using 3 day urinary diary and Patient Global Impression of Improvement (PGI-I)
- King's quality of life questionnaire
- Repeat urodynamic studies as described previously, including voiding cystometry (6 months only)
- Any complications noted, e.g. readmission to hospital, UTI, voiding difficulties
- Patient satisfaction will be assessed using a 5 point scale at the follow up visit
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Randomized Study of the Treatment of Urodynamic Stress Incontinence: the Tension Free Vaginal Tape (TVT) Versus the Miniarc Sling.|
|Study Start Date :||February 2008|
|Actual Primary Completion Date :||March 2009|
|Actual Study Completion Date :||August 2009|
Active Comparator: TVT
Women in this arm will undergo the Tension Free Vaginal Tape procedure
Device: Tension Free Vaginal Tape
Tension Free Vaginal Tape inserted in the conventional manner in a theatre environment
Other Name: Advantage TVT, Boston Scientific
Women in this group will undergo the Miniarc suburethral sling procedure
The Miniarc suburethral sling will be inserted in the conventional manner in a theatre environment under general anaesthesia
Other Name: Miniarc, American Medical Systems
- The absence of stress incontinence at 6 weeks ascertained by direct questioning and from the Kings Quality of life questionnaire and the absence at 6 months by the same criteria and by urodynamics. [ Time Frame: 6 weeks and 6 months ]
- Quality of life (as measured using the King's Health Questionnaire) [ Time Frame: 6 weeks and 6 months ]
- Intra-operative complications, e.g. bladder injury [ Time Frame: Time of surgery ]
- Post-operative voiding dysfunction [ Time Frame: 0-6 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00843908
|Medway Maritime Hospital|
|Gillingham, Kent, United Kingdom, ME7 5NY|